Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

Plus, when to see a doctor.

Common symptoms like shortness of breath or a lingering cough may seem harmless, but when they persist, they could point to ...

Clinical trial designed to evaluate ROC-101 in combination with standard of care therapies including sotatercept NATICK, Mass. /PRNewswire/ -- AllRock Bio, Inc., a ...

Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, ...

C-mo Medical Solutions receives CE Mark for its novel AI-powered cough monitoring in patients: Lisbon, Portugal Saturday, April 18, 2026, 10:00 Hrs [IST] C-mo Medical Solutions, a ...

Regulatory milestone supports broader adoption of C-mo's privacy-preserving technology in clinical research and medical practiceApproval covers the biosensor, automated cough monitoring algorithms and ...

Five years after Pete Pearson, 75, was diagnosed with a terminal lung condition, he was experiencing debilitating anxiety and depression known as "end-of-life distress." He wanted to try psilocybin — ...

Shelley Harris, an Oak Park Public Library employee, hosted a healing circle event for people to share their experiences and ...

No AI-discovered drug has been approved. 40 million people use ChatGPT for health advice daily. A reality check on what AI ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

The FDA has approved Cipla's nintedanib capsules as a new generic version of Ofev for treating idiopathic pulmonary fibrosis ...